Custopharm FLUDARABINE PHOSPHATE FOR INJECTION, USP, 50 mg per vial, Single dose vial recall — FDA D-0765-2021
Lack of Assurance of Sterility: the manufacturing firm had microbial recoveries during environmental monitoring in aseptic areas of manufacturing.